Synapticure Press Releases

April 15, 2024

Synapticure and the ALS Association Partner to Expand Telehealth Access for People Living with ALS Nationwide

September 6, 2023

Synapticure Welcomes Joe Leinbach as Chief Operating Officer and Expands Coverage to Additional Neurological Conditions

June 6, 2023

Announcing a New Advisory Relationship with The Michael J. Fox Foundation

November 14, 2022

Parkinson’s Launch Announcement

September 13, 2022

Spirometer Launch Announcement

May 3, 2022

Synapticure Grows Leadership Team, Hires Neurologists as Company Scales

February 1, 2022

Synapticure Launches to Transform Standard of Care for People Living with ALS and Beyond With $6M in Seed Funding Led by GV

It is time to leave behind the era of

“I’m sorry but we can’t help you.”

Book your visit
Patients & Families
How It WorksFrequently Asked Questions
For Partners
ProvidersPayersGUIDEResearch
Our Services
Alzheimer's DiseaseFrontotemporal DementiaALS & PLSParkinson's DiseaseHuntington's DiseaseMental Health Care
About us
Leadership TeamOur CliniciansCareersCollaborators & SupportersContact
Resources
Our BlogPress Releases
Legal
Privacy PolicyTerms of ServiceNotice of Privacy PracticesTelehealth Informed ConsentFCOI

This office appreciates the diversity of human beings and does not discriminate based on race, age, religion, ability,  marital status, sexual orientation, sex or gender identity.

Synapticure logo whitePh: +1 708-630-1534
Fax: +1 888-517-8619

2045 W Grand Ave Ste B Chicago, IL 60612

AICPA SOC 2 logo
© Copyright Synapticure. All rights reserved.